GROWTH IN News & Analysis

Not all sources of investment edge are accessible to everyday investors. This one might be, but it takes courage.

Tesla’s current product lineup may have reached market saturation. But investors have high hopes its robotaxi business.

This healthcare company still has plenty of growth potential, but it’s been a rocky road for investors recently.

For much of Australia’s history, each new generation has been better off than the last: better jobs and incomes as well as improved living standards....

Cochlear’s biggest market segment has matured and it is looking elsewhere for growth.

Monster's share price is up over 18 times since I first came across its products in the late noughties. What can we learn from its rise?

In the life insurance software industry, growth requires patience. Shaun Ler thinks this ASX listed firm is positioned to win.

WiseTech’s latest acquisition is bigger than its previous 55 combined. Integration could be challenging but the timing looks right.

WiseTech’s competitive position is incredibly strong and looks set to underpin formidable sales growth for the foreseeable future.

And our equity analysts’ outlook for the stocks.